Total Payments
$7,612
2024 Payments
$1,261
Companies
40
Transactions
467
Medicare Patients
7,642
Medicare Billing
$360,259
Payment Breakdown by Category
Food & Beverage$7,575 (99.5%)
Education$36.47 (0.5%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,575 | 463 | 99.5% |
| Education | $36.47 | 4 | 0.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $1,219 | 71 | $0 (2024) |
| Lilly USA, LLC | $659.89 | 47 | $0 (2024) |
| PFIZER INC. | $639.61 | 45 | $0 (2024) |
| ABBVIE INC. | $617.09 | 34 | $0 (2024) |
| Amgen Inc. | $543.69 | 33 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $472.57 | 34 | $0 (2024) |
| GlaxoSmithKline, LLC. | $409.15 | 27 | $0 (2024) |
| Astellas Pharma US Inc | $399.57 | 22 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $273.39 | 16 | $0 (2022) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $240.28 | 14 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,261 | 71 | Novo Nordisk Inc ($281.26) |
| 2023 | $1,407 | 84 | Novo Nordisk Inc ($242.03) |
| 2022 | $752.81 | 42 | Lilly USA, LLC ($131.63) |
| 2021 | $13.26 | 1 | AstraZeneca Pharmaceuticals LP ($13.26) |
| 2020 | $272.76 | 18 | PFIZER INC. ($42.25) |
| 2019 | $1,555 | 96 | Amgen Inc. ($219.20) |
| 2018 | $1,547 | 104 | Novo Nordisk Inc ($239.45) |
| 2017 | $802.50 | 51 | Novo Nordisk Inc ($210.44) |
All Payment Transactions
467 individual payment records from CMS Open Payments — Page 1 of 19
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/24/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $24.05 | General |
| Category: Obesity | ||||||
| 09/23/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $24.80 | General |
| Category: PAIN | ||||||
| 09/10/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $20.83 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 09/09/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $17.55 | General |
| Category: UROLOGY | ||||||
| 09/04/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.82 | General |
| Category: Diabetes | ||||||
| 08/28/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $18.73 | General |
| Category: Diabetes | ||||||
| 08/21/2024 | Xeris Pharmaceuticals, Inc. | GVOKE HYPOPEN (Drug) | Food and Beverage | In-kind items and services | $15.83 | General |
| Category: Diabetes | ||||||
| 08/21/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $14.56 | General |
| Category: Bone Health | ||||||
| 08/19/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $19.84 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/14/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $16.92 | General |
| Category: Diabetes | ||||||
| 08/13/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $14.61 | General |
| Category: Diabetes | ||||||
| 08/08/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $14.82 | General |
| Category: RESPIRATORY | ||||||
| 08/07/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $32.46 | General |
| Category: Psychology/Psychiatric | ||||||
| 08/06/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $17.45 | General |
| Category: UROLOGY | ||||||
| 07/31/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.53 | General |
| Category: NEUROSCIENCE | ||||||
| 07/29/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $19.37 | General |
| Category: Biological | ||||||
| 07/29/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $13.24 | General |
| Category: VACCINES | ||||||
| 07/25/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $19.58 | General |
| Category: Diabetes | ||||||
| 07/24/2024 | Lilly USA, LLC | ZEPBOUND (Drug) | Food and Beverage | In-kind items and services | $10.38 | General |
| Category: Obesity | ||||||
| 07/23/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $15.95 | General |
| Category: Bone Health | ||||||
| 07/17/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $13.70 | General |
| Category: Diabetes | ||||||
| 07/16/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $26.86 | General |
| Category: RESPIRATORY | ||||||
| 07/09/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $17.81 | General |
| Category: Obesity | ||||||
| 07/09/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $16.43 | General |
| Category: UROLOGY | ||||||
| 06/26/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $19.09 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 39 | 1,967 | 2,792 | $237,765 | $99,216 |
| 2022 | 41 | 1,966 | 2,812 | $220,166 | $90,530 |
| 2021 | 42 | 2,194 | 3,253 | $244,537 | $105,291 |
| 2020 | 30 | 1,515 | 2,019 | $172,071 | $65,222 |
Total Patients
7,642
Total Services
10,876
Medicare Billing
$360,259
Procedure Codes
152
All Medicare Procedures & Services
152 procedure records from CMS Medicare Utilization — Page 1 of 7
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 229 | 578 | $90,995 | $47,931 | 52.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 89 | 89 | $14,580 | $10,896 | 74.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 108 | 145 | $15,580 | $8,420 | 54.0% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 54 | 54 | $5,400 | $3,884 | 71.9% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 184 | 329 | $4,935 | $2,723 | 55.2% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 12 | 12 | $7,920 | $2,501 | 31.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 15 | 16 | $3,385 | $2,110 | 62.3% |
| 77067 | Screening mammography | Office | 2023 | 24 | 24 | $7,680 | $1,978 | 25.8% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 92 | 121 | $8,470 | $1,942 | 22.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 59 | 59 | $2,360 | $1,674 | 71.0% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 99 | 147 | $6,615 | $1,390 | 21.0% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 133 | 178 | $7,120 | $1,349 | 18.9% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 94 | 100 | $7,000 | $1,312 | 18.7% |
| 82306 | Vitamin d-3 level | Office | 2023 | 39 | 44 | $4,840 | $1,276 | 26.4% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 94 | 110 | $6,600 | $1,139 | 17.3% |
| 83970 | Parathormone (parathyroid hormone) level | Office | 2023 | 23 | 27 | $4,185 | $1,062 | 25.4% |
| 87635 | Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2023 | 14 | 20 | $3,200 | $1,006 | 31.4% |
| 80069 | Kidney function blood test panel | Office | 2023 | 84 | 107 | $6,420 | $893.55 | 13.9% |
| 82607 | Cyanocobalamin (vitamin b-12) level | Office | 2023 | 48 | 54 | $3,510 | $798.12 | 22.7% |
| 84439 | Thyroxine (thyroid chemical), free | Office | 2023 | 54 | 70 | $3,150 | $618.80 | 19.6% |
| 77063 | Screening 3d breast mammography | Office | 2023 | 24 | 24 | $1,680 | $513.84 | 30.6% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 26 | 52 | $2,705 | $507.36 | 18.8% |
| 87086 | Bacterial colony count, urine | Office | 2023 | 35 | 49 | $2,205 | $387.59 | 17.6% |
| 82746 | Folic acid level, serum | Office | 2023 | 26 | 26 | $1,950 | $374.66 | 19.2% |
| 82728 | Ferritin (blood protein) level | Office | 2023 | 24 | 27 | $2,295 | $350.93 | 15.3% |
About Dr. Mary Barfield, MD
Dr. Mary Barfield, MD is a Family Medicine healthcare provider based in Cartersville, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/25/2006. The National Provider Identifier (NPI) number assigned to this provider is 1184647984.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mary Barfield, MD has received a total of $7,612 in payments from pharmaceutical and medical device companies, with $1,261 received in 2024. These payments were reported across 467 transactions from 40 companies. The most common payment nature is "Food and Beverage" ($7,575).
As a Medicare-enrolled provider, Barfield has provided services to 7,642 Medicare beneficiaries, totaling 10,876 services with total Medicare billing of $360,259. Data is available for 4 years (2020–2023), covering 152 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Cartersville, GA
- Active Since 07/25/2006
- Last Updated 05/08/2020
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1184647984
Products in Payments
- Ozempic (Drug) $402.79
- VRAYLAR (Drug) $349.62
- FARXIGA (Drug) $325.15
- JARDIANCE (Drug) $282.50
- TRULICITY (Drug) $258.74
- TRELEGY ELLIPTA (Drug) $236.98
- ELIQUIS (Drug) $236.25
- Dexcom G6 Transmitter (Medical Supply) $191.61
- Wegovy (Drug) $190.22
- ENTRESTO (Drug) $188.96
- MOUNJARO (Drug) $186.62
- EVENITY (Biological) $185.76
- Victoza (Drug) $175.68
- Aimovig (Biological) $171.53
- Tresiba (Drug) $155.26
- XARELTO (Drug) $155.08
- VESICARE (Drug) $154.86
- TOUJEO (Drug) $150.98
- Rybelsus (Drug) $150.96
- LINZESS (Drug) $142.47
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Cartersville
Louis Spencer, M.d, M.D
Family Medicine — Payments: $12,393
Family Medicine $12,393
Dr. Carl Bevill, Md, MD
Family Medicine — Payments: $12,235
Family Medicine $12,235
Mr. Lee Battle, Md, MD
Family Medicine — Payments: $6,097
Family Medicine $6,097
Dr. James Williams, Md, MD
Family Medicine — Payments: $5,932
Family Medicine $5,932
Dr. Richard Britton, D.o, D.O
Family Medicine — Payments: $5,359
Family Medicine $5,359
Robin Rodgers, Md, MD
Family Medicine — Payments: $5,044
Family Medicine $5,044